Bayesian cost-effectiveness analysis from clinical trial data

89Citations
Citations of this article
52Readers
Mendeley users who have this article in their library.
Get full text

Abstract

A key tool for assessing the relative cost-effectiveness of two treatments in health economics is the incremental C/E acceptability curve. We present Bayesian computations for this curve in the case where data on both costs and efficacy are available from a clinical trial. Analysis is given under various formulations of prior information. A case study is analysed in which reasonable prior information is shown to strengthen substantially the posterior inference, leading to a more conclusive assessment of cost-effectiveness. Calculations can be performed using readily available Bayesian software. Copyright © 2001 John Wiley & Sons, Ltd.

Cite

CITATION STYLE

APA

O’Hagan, A., Stevens, J. W., & Montmartin, J. (2001). Bayesian cost-effectiveness analysis from clinical trial data. Statistics in Medicine, 20(5), 733–753. https://doi.org/10.1002/sim.861

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free